192 related articles for article (PubMed ID: 27846839)
1. Combination therapy only shows short-term superiority over monotherapy on ureteral stent-related symptoms - outcome from a randomized controlled trial.
Liu Q; Liao B; Zhang R; Jin T; Zhou L; Luo D; Liu J; Li H; Wang K
BMC Urol; 2016 Nov; 16(1):66. PubMed ID: 27846839
[TBL] [Abstract][Full Text] [Related]
2. The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis.
Wang J; Zhang X; Zhang T; Mu J; Bai B; Lei Y
World J Urol; 2017 Nov; 35(11):1669-1680. PubMed ID: 28550362
[TBL] [Abstract][Full Text] [Related]
3. A critical assessment of the effects of tamsulosin and solifenacin as monotherapies and as a combination therapy for the treatment of ureteral stent-related symptoms: a 2 × 2 factorial randomized trial.
Park J; Yoo C; Han DH; Shin DW
World J Urol; 2015 Nov; 33(11):1833-40. PubMed ID: 25809877
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms.
El-Nahas AR; Tharwat M; Elsaadany M; Mosbah A; Gaballah MA
World J Urol; 2016 Jul; 34(7):963-8. PubMed ID: 26453222
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
[TBL] [Abstract][Full Text] [Related]
6. Tamsulosin Monotherapy Is Effective in Reducing Ureteral Stent-related Symptoms: A Meta-analysis of Randomized Controlled Studies.
Chen YB; Gao L; Jiang Q; Ran K; Luo RT
Curr Med Sci; 2019 Oct; 39(5):707-718. PubMed ID: 31612387
[TBL] [Abstract][Full Text] [Related]
7. [Cost-effectiveness model of a fixed dose combination of solifenacin and tamsulosin for the treatment of LUTS associated with BPH with inadequate response to monotherapy.].
Alcántara A; Cózar JM; Errando C; Rubio-Rodríguez D; Rubio-Rodríguez D; Rubio-Terrés C; Mora AM; Duran A
Arch Esp Urol; 2018 Sep; 71(7):595-606. PubMed ID: 30198851
[TBL] [Abstract][Full Text] [Related]
8. Tamsulosin, Solifenacin, and Their Combination for the Treatment of Stent-Related Symptoms: A Randomized Controlled Study.
Dellis AE; Papatsoris AG; Keeley FX; Bamias A; Deliveliotis C; Skolarikos AA
J Endourol; 2017 Jan; 31(1):100-109. PubMed ID: 27809592
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results from the randomised controlled NEPTUNE trial.
van Kerrebroeck P; Chapple C; Drogendijk T; Klaver M; Sokol R; Speakman M; Traudtner K; Drake MJ;
Eur Urol; 2013 Dec; 64(6):1003-12. PubMed ID: 23932438
[TBL] [Abstract][Full Text] [Related]
10. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial.
Sivalingam S; Streeper NM; Sehgal PD; Sninsky BC; Best SL; Nakada SY
J Urol; 2016 Feb; 195(2):385-90. PubMed ID: 26393904
[TBL] [Abstract][Full Text] [Related]
11. Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men.
Chan R; Munoz A; Wenker EP; Whipple M; Miles B; Boone TB
Urology; 2016 May; 91():150-3. PubMed ID: 26829718
[TBL] [Abstract][Full Text] [Related]
12. Rate and associated factors of solifenacin add-on after tamsulosin monotherapy in men with voiding and storage lower urinary tract symptoms.
Lee HN; Lee KS; Kim JC; Chung BH; Kim CS; Lee JG; Kim DK; Park CH; Park JK; Hong SJ
Int J Clin Pract; 2015 Apr; 69(4):444-53. PubMed ID: 25363606
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled trial to compare solifenacin versus trospium chloride in the relief of double-J stent-related symptoms.
Abdelhamid MH; Zayed AS; Ghoneima WE; Elmarakbi AA; El Sheemy MS; Aref A; Abdelbary A; Nour HH
World J Urol; 2017 Aug; 35(8):1261-1268. PubMed ID: 28050642
[TBL] [Abstract][Full Text] [Related]
14. [A Crossover Comparison Study on Lower Urinary Tract Symptoms with Overactive Bladder Secondary to Benign Prostatic Hyperplasia: Naftopidil versus Tamsulosin with Solifenacin].
Utsunomiya N; Matsumoto K; Tsunemori H; Muguruma K; Kawakita M; Kamiyama Y; Kanamaru S; Ito N; Tsukazaki H; Shirahase T; Takahashi T
Hinyokika Kiyo; 2016 Jul; 62(7):341-7. PubMed ID: 27569351
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with tamsulosin and solifenacin for male lower urinary tract symptoms with predominant filling symptoms: a new approach to an old problem.
Angulo JC
Curr Med Res Opin; 2015 Nov; 31(11):1963-5. PubMed ID: 26368336
[TBL] [Abstract][Full Text] [Related]
16. The evolving picture of lower urinary tract symptom management.
Tubaro A; De Nunzio C; Puccini F; Presicce F
Eur Urol; 2015 Feb; 67(2):271-2. PubMed ID: 25457016
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
Nazir J; Heemstra L; van Engen A; Hakimi Z; Ivanescu C
BMC Urol; 2015 May; 15():41. PubMed ID: 25956727
[TBL] [Abstract][Full Text] [Related]
18. Solifenacin improves double-J stent-related symptoms in both genders following uncomplicated ureteroscopic lithotripsy.
Lee YJ; Huang KH; Yang HJ; Chang HC; Chen J; Yang TK
Urolithiasis; 2013 Jun; 41(3):247-52. PubMed ID: 23515684
[TBL] [Abstract][Full Text] [Related]
19. Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony).
Abrams P; Kelleher C; Staskin D; Rechberger T; Kay R; Martina R; Newgreen D; Paireddy A; van Maanen R; Ridder A
Eur Urol; 2015 Mar; 67(3):577-88. PubMed ID: 24612659
[TBL] [Abstract][Full Text] [Related]
20. [Tamsulosin, oxybutynin or their combination in the treatment of ureteral stent-related symptoms].
Maldonado-Alcaraz E; Moreno-Palacios J; López-Sámano VA; Landa-Salas JD; Torres-Mercado LO; García-Cruz C
Rev Med Inst Mex Seguro Soc; 2017; 55(5):568-574. PubMed ID: 29193937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]